Novartis, Roche caught up in French antitrust probe
This article was originally published in Scrip
Executive Summary
France's competition authority is investigating Swiss big pharmas Novartis and Roche on suspicions they are colluding in anticompetitive activities preventing the use of the anticancer Avastin (Roche's bevacizumab) in ophthalmic indications in the country.